Boehringer Ingelheim Investigational Site

Ottawa, Ontario K2P 1V3

0 studies enrolling now · 3 studies all time

What they study most

Arthritis, Rheumatoid, HIV Infections, Pulmonary Disease, Chronic Obstructive

Studies at this site

• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed
• Tiotropium / Respimat One-Year Study — Completed
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed